All News

Found 17,381 articles

• The Mattson Jack Group, Inc. Announces the Release of CancerNSight(TM)

  10/4/2007

• Novartis Vaccines & Diagnostics, Inc. Launches National Gift-Giving Program

  10/3/2007

• FDA Reviews Merck & Co., Inc. (Jobs) and Novartis International AG's Osteoporosis Drugs' Effect on Heart

  10/2/2007

• ChemGenex Pharmaceuticals Limited Announces Positive Preliminary Data From Phase 2/3 Clinical Trial of Ceflatonin(R) at International Conference

  10/1/2007

• Teva Pharmaceutical Industries Limited Announces Court of Appeals Denies Novartis International AG's Emergency Motion on Generic Famvir(R)

  10/1/2007

• Novartis International AG Invests $65 Million to Develop Manufacturing

  9/28/2007

• Novartis International AG Diabetes Drug Galvus Approved in Europe

  9/28/2007

• Idenix Pharmaceuticals, Inc. Restructures to Concentrate Efforts on HCV and HIV Programs; Reduces Workforce

  9/28/2007

• Novartis International AG Painkiller Prexige Gets "Not Approvable" Letter in U.S.

  9/27/2007

• Galapagos NV and ProStrakan Group Receive Additional Milestone Payment in Antibody Collaboration

  9/27/2007

• Jeremy Levin Joins Bristol-Myers Squibb Company as Senior Vice President of External Science, Technology and Licensing

  9/27/2007

• Antibody Engineering Company f-Star Appoints Geert Mudde as Chief Scientific Officer

  9/25/2007

• Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors

  9/25/2007

• MedImmune, Inc. Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production

  9/24/2007

• Speedel Holding AG And Novartis Pharmaceuticals Corporation Win The Wall Street Journal Gold Award

  9/24/2007

• ARx Opens New Pharmaceutical Manufacturing Facility

  9/20/2007

• Lorus Therapeutics Inc. Announces Election of Three New Directors and Appoints New Chairman

  9/20/2007

• Alnylam Pharmaceuticals (Jobs) Announces the Termination of its Collaboration with Merck & Co., Inc. (Jobs)

  9/19/2007

• Novartis Corporation (Jobs) Bone Drug Cuts Death After Hip Fractures in Study

  9/18/2007

• MorphoSys AG Announces Clinical Milestone in Antibody Program -- Fourth HuCAL-based Antibody to Begin Clinical Trials

  9/18/2007